Medicare Enrolled
Dr. Ariel Majjhoo
Pain Medicine (Psychiatry & Neurology) Physician · Monroe, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Majjhoo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Majjhoo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Majjhoo
Dr. Ariel Majjhoo is a pain medicine physician in Monroe, MI, with 18 years of NPI registration. Based on federal Medicare data, Dr. Majjhoo performed 3,681 Medicare services across 931 unique beneficiaries.
Between the years covered by Open Payments, Dr. Majjhoo received a total of $151,428 from 86 pharmaceutical and/or device companies across 1578 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine (psychiatry & neurology) physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Majjhoo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ 3,681 Medicare services
$151,428 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,681
Medicare services
1.0× state median for pain medicine (psychiatry & neurology) physician
931
Unique beneficiaries
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~204 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,155 | $0 | $3 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,012 | $62 | $200 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
836 | $88 | $300 |
| Injection, methylprednisolone acetate, 40 mg | 112 | $6 | $25 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
56 | $1 | $10 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
51 | $50 | $323 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
47 | $61 | $152 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
46 | $188 | $888 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
44 | $98 | $450 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
41 | $9 | $25 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
37 | $114 | $500 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
35 | $35 | $100 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
32 | $177 | $1,263 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
31 | $463 | $2,143 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
30 | $278 | $881 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
25 | $106 | $291 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
22 | $147 | $825 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
21 | $200 | $1,128 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
19 | $63 | $150 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
15 | $171 | $982 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
14 | $92 | $487 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$151,428
Total received (2018-2024)
Avg $21,633/year across 7 years
Top 0% in MI for pain medicine (psychiatry & neurology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
86
Companies
1,578
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$87,167 (57.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$56,368 (37.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,894 (5.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$10,944
2023
$13,612
2022
$13,560
2021
$21,352
2020
$25,769
2019
$32,896
2018
$33,296
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$5,008
Spinal Simplicity, LLC
$1,631
Nalu Medical, Inc.
$757
Nevro Corp.
$619
Boston Scientific Corporation
$589
Medtronic, Inc.
$501
Saluda Medical Americas, Inc.
$234
Abbott Laboratories
$186
MML US, Inc.
$184
SPR Therapeutics, Inc
$172
Vertos Medical, Inc.
$163
Collegium Pharmaceutical, Inc.
$152
AstraZeneca Pharmaceuticals LP
$145
SI-BONE, INC.
$132
E.R. Squibb & Sons, L.L.C.
$126
Neurocrine Biosciences, Inc.
$125
PFIZER INC.
$99
PAINTEQ LLC
$70
Teva Pharmaceuticals USA, Inc.
$29
SCILEX PHARMACEUTICALS INC.
$21
Top 3 companies account for 67.6% of 2024 payments
All-time payments by company (2018-2024) ›
Horizon Therapeutics plc
$36,214
BioDelivery Sciences International, Inc.
$17,784
Daiichi Sankyo Inc.
$17,449
Nevro Corp.
$10,628
ABBVIE INC.
$9,703
Pernix Therapeutics Holdings, Inc.
$7,600
Boston Scientific Corporation
$5,938
Medtronic, Inc.
$5,098
Medtronic USA, Inc.
$4,467
Allergan, Inc.
$4,140
Spinal Simplicity, LLC
$3,898
Vertos Medical, Inc.
$3,424
Nalu Medical, Inc.
$3,311
Relievant Medsystems, Inc.
$1,749
MML US, Inc.
$1,601
Vertiflex, Inc.
$1,540
Abbott Laboratories
$1,533
Neuronetics, Inc.
$1,386
BOSTON SCIENTIFIC CORPORATION
$1,193
Collegium Pharmaceutical, Inc.
$1,144
Amgen Inc.
$1,110
Lilly USA, LLC
$827
AstraZeneca Pharmaceuticals LP
$674
Nutech Spine, Inc.
$456
Teva Pharmaceuticals USA, Inc.
$417
Almatica Pharma LLC
$387
SPR Therapeutics, Inc
$342
Stimwave Technologies Incorporated
$340
Purdue Pharma L.P.
$321
PFIZER INC.
$317
Nuvectra Corporation
$308
INSYS Therapeutics Inc
$267
Supernus Pharmaceuticals, Inc.
$264
Scilex Pharmaceuticals Inc.
$263
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$262
Saluda Medical Americas, Inc.
$234
SI-BONE, INC.
$233
West Therapeutics Development, LLC
$224
Biohaven Pharmaceutical Holding Company Ltd.
$208
Horizon Pharma plc
$194
Alexion Pharmaceuticals, Inc.
$192
Sentynl Therapeutics, Inc.
$189
Vertical Pharmaceuticals, LLC
$187
GRT US Holding, Inc.
$181
Pacira Pharmaceuticals Incorporated
$170
AbbVie Inc.
$164
Jazz Pharmaceuticals Inc.
$157
UPSHER-SMITH LABORATORIES LLC
$144
Medtronic Vascular, Inc.
$129
E.R. Squibb & Sons, L.L.C.
$126
UCB, Inc.
$125
Neurocrine Biosciences, Inc.
$125
SCILEX PHARMACEUTICALS INC.
$122
TerSera Therapeutics LLC
$121
Chiesi USA, Inc.
$117
IMPEL PHARMACEUTICALS INC.
$117
Janssen Pharmaceuticals, Inc
$115
Novartis Pharmaceuticals Corporation
$112
Egalet US Inc
$111
Allergan Inc.
$104
Lundbeck LLC
$92
Zyla Life Sciences, Inc.
$88
Biohaven Pharmaceuticals, Inc.
$83
Takeda Pharmaceuticals U.S.A., Inc.
$80
Upsher-Smith Laboratories LLC
$72
Shionogi Inc
$70
PAINTEQ LLC
$70
Bioventus LLC
$64
ASSERTIO THERAPEUTICS, Inc.
$63
Virtus Pharmaceuticals LLC
$58
Zyla Life Sciences
$54
Biogen, Inc.
$48
RedHill Biopharma Inc.
$46
IDORSIA PHARMACEUTICALS US INC
$44
Kaleo, Inc.
$40
IBSA Pharma Inc.
$25
AcelRx Pharmaceuticals, Inc.
$24
Metacel Pharmaceuticals LLC
$24
Averitas Pharma Inc.
$23
SANOFI-AVENTIS U.S. LLC
$19
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$18
SI-BONE, Inc.
$17
Ferring Pharmaceuticals Inc.
$16
Avanos Medical
$13
Orthogenrx Inc.
$13
Flexion Therapeutics, Inc.
$12
Top 3 companies account for 47.2% of all-time payments
Associated products mentioned in payments ›
ADAPTIVESTIM · ADUHELM · AIMOVIG · AJOVY · ANDEXXA · ARYMO ER · Aimovig · Algovita · Amitiza · Andexxa · Austedo XR · Axium Sheath Braided DRG · BELBUCA · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BUNAVAIL 2.1 mg 30-count box · Belbuca · Briviact · CLEVIPREX · COMIRNATY · DSUVIA · DUEXIS · Durolane · EMGALITY · EUFLEXXA · EVENITY · Evoke · Evzio · FLECTOR · GENERAL THERAPIES · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GENERATOR · GRALISE · GenVisc 850 · General - Therapies · Gralise · HA MINUTEMAN G3-R · IFUSE IMPLANT · INGREZZA · INJECTAFER · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · Iovera · KRYSTEXXA · LEVORPHANOL TARTRATE · LIBERTY SI · LORZONE · LYRICA · Lazanda · Levorphanol · Levorphanol Tartrate · Licart · METHYLPHENIDATE 72 · MOVANTIK · Morphabond ER · Movantik · NAPRELAN · NEUROSTAR TMS THERAPY SYSTEM · NURTEC ODT · Nalu Neurostimulation System · Nucynta · OSTEOCOOL RF ABLATION · Omnia · Ozobax · PAINTEQ · PENNSAID · PRIALT · PRIMARY CARE - DISEASE STATE · PROCLAIM · Prialt · Proclaim Family of SCS IPGs · Proclaim IPG · QULIPTA · QUTENZA · QUVIVIQ · Qutenza · RAYOS · RELEXXII · RELISTOR · REYVOW · ReActiv8 · Reveal LINQ · RoxyBond · SCS IPGs · SILENOR · SPECTRA WAVEWRITER · SPRINT PNS System · SPRIX · SUBSYS · SUPERION · SYMPROIC · SYNCHROMED · SYNCHROMEDII · SYNDROS · SYNVISC-ONE · Senza · Senza Spinal Cord Stimulation System · Sifix · Soliris · Subsys · Supartz · Superion · Superion ISS · Superion Indirect Decompression System · Symproic · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · Trudhesa · UBRELVY · ULTOMIRIS · VECTRIS · VIMOVO · VRAYLAR · VYEPTI · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XARELTO · XIFAXANIBSD · XTAMPZA · XTAMPZAER · Xtampza ER · ZEPOSIA · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · Zipsor · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (58%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pain medicine (psychiatry & neurology) physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for pain medicine (psychiatry & neurology) physician in MI.
Geographic Context
Pain medicine physicians within 10 mi
1
Per 100K population
0.6
County median income
$75,272
Nearest hospital
PROMEDICA MONROE REGIONAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Majjhoo is a clinical cardiology specialist, with speaking/promotional industry engagement in the top 0% of MI peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Majjhoo experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Majjhoo performed 1,155 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Majjhoo receive payments from pharmaceutical companies?
Yes. Dr. Majjhoo received a total of $151,428 from 86 companies across 1,578 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Majjhoo's costs compare to other pain medicine physicians in Monroe?
Dr. Majjhoo's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Majjhoo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicine Physicians in Monroe
Browse pain medicine physicians in Monroe ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicine Physicians in MI
Pain medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicine Physicians in MI
Which MI pain medicine physicians receive the most from drug and device companies.
By company
Horizon Therapeutics plc Payments to Doctors
See all physicians who received payments from Horizon Therapeutics plc.
By company
BioDelivery Sciences International, Inc. Payments to Doctors
See all physicians who received payments from BioDelivery Sciences International, Inc.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology